Citi Pharma Limited (PSX: CPHL) has successfully completed its first export order to the Middle East and North Africa (MENA). The export, valued at EUR 560,000, was secured following the company’s FDA accreditation announced on September 20, 2024, CPHL informed the main bourse on Thursday.
Of the €500,000, CPHL had previously received an advance payment of €200,000. “Today, we have received the remaining balance of EUR 360,000, finalizing this initial export transaction”.
CPHL said that overall, it is eyeing a total export value of at least €8,000,000 to €10,000,000 annually to the MENA Region to the International Market and a similar amount to other International Markets including North America.
This achievement paves the way for Citi Pharma Limited’s growth in the international markets, strengthening our presence and unlocking new opportunities for the company, the filing added.
The principal activity of the company is the manufacturing and sale of pharmaceuticals, medical chemicals, and botanical products.
